SU CHEN: Open Payments
NPI 1396308946 · LEAGUE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 58 payments from 14 companies in 2025. Trend: 2023 $138 · 2024 $882 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $285 |
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| Viatris Specialty LLC | 5 | $126 |
| Insmed, Inc. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $113 |
| Philips North America LLC | 4 | $82 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| JAZZ PHARMACEUTICALS INC. | 2 | $58 |
| Inspire Medical Systems, Inc. | 2 | $52 |
| Verona Pharma, Inc. | 2 | $44 |
Products named: NUCALA, TRELEGY ELLIPTA, YUPELRI, Arikayce, ARALAST, TEZSPIRE, Vest Therapy Und, ZERBAXA.
Industry payments across TX — which companies pay providers there.
